Ethical aspects of vaccines and vaccination

Vaccine

Volumn 16, Issue 19, 1998, Pages 1788-1794

  Spier, R E ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BIOLOGICAL WARFARE; CONFERENCE PAPER; COST BENEFIT ANALYSIS; CULTURAL FACTOR; HUMAN; LICENCE; MEDICAL ETHICS; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY CONTROL; VACCINATION; VACCINE PRODUCTION;

AUTONOMY; CLINICAL APPROACH/SOURCE; COMPENSATION; COSTS AND BENEFITS; CULTURAL PLURALISM; HEALTH CARE AND PUBLIC HEALTH; INJURIES; INTERNATIONAL ASPECTS; JUSTICE; RISKS AND BENEFITS; VALUES;

BENEFICENCE; COMPENSATION AND REDRESS; COST-BENEFIT ANALYSIS; CULTURAL DIVERSITY; CULTURE; ETHICS, MEDICAL; GENETIC ENHANCEMENT; HUMANS; INTERNATIONALITY; PERSONAL AUTONOMY; RISK ASSESSMENT; SOCIAL VALUES; VACCINATION; VACCINES;

EID: 0032210861     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00169-8     Document Type: Conference Paper

References (16)

1. 1 Spier, R. E. Introducing fence vaccines. Vaccine 1997, 15, 1289-1290.
2. 2 The State of the World's Children. Unicef, Oxford University Press, Oxford, 1996, p.99.
3. 3 Nuffield Council on Bioethics, 1995, Human Tissue Ethical and Legal Issues. Nuffield Council on Bioethics, London, UK, 1995.
4. 4 Kirkpatrick, The Analysis of Inoculation Comprising the History, Theory and Practice of It: With an Occasional Consideration of the most Remarkable Appearances in the SMALL POCKS. 2nd ed. Buckland and Griffiths, London, 1761, p. 380.
5. 5 The Times, London, 1995, 2 November p. 5; 5 November p. 19; 7 November p. 16; 9 November p. 19.
6. 5 The Times, London, 1995, 2 November p. 5; 5 November p. 19; 7 November p. 16; 9 November p. 19.
7. 5 The Times, London, 1995, 2 November p. 5; 5 November p. 19; 7 November p. 16; 9 November p. 19.
8. 5 The Times, London, 1995, 2 November p. 5; 5 November p. 19; 7 November p. 16; 9 November p. 19.
9. 6 Leviticus 26:21, 25.
10. 7 Boyce, N., In sickness and in health. New Scientist, 156 (1997) 25 October, 20-21.
11. 8 Steve Connor, The Sunday Times, 12/4/1998, News Section p.6 which describes a genetically engineered anti-pregnancy oral vaccine based on Salmonella.
12. 9 Nara, P. L., Merges, M. J., Conley, Sr. Evidence of cryptic V3 epitope(s) on native HIV-1 virions: immunophysicochemical analysis. In: Norrby, E., Brown, F., Chanock, R. M., Ginsberg, H. S. (Eds.), Vaccines 94. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1994, pp. 155-159.
13. 10 Garrett, L., The Coming Plague; Newly Emerging Diseases in a World out of Balance. Straus and Giroux, New York, 1994, 750 pp.
14. 11 Spier, R. E. On the acceptibility of biopharmaceuticals. Science and Engineering Ethics 1996, 2, 291-306.
15. 12 Spier, R. E. Ethical aspects of the university-industry interface. Science and Engineering Ethics 1995, 1, 151-162.
16. 13 Spier, R. E. Ethics as a control system component. Science and Engineering Ethics 1992, 2, 259-262.